Company profile
Cambridge Oncometrix company profile
Cambridge Oncometrix aims to save lives by enabling the early detection of prostate cancer - a condition that affects 1 in 7 men on the planet. The company develops a non-invasive risk stratification test for prostate cancer. The laboratory test will be capable of accurately selecting men for mpMRI-guided biopsy.
Business identity
- Contact email
- [email protected]
- Phone number
- +441603 274 521
- Operating status
- Closed
- Company type
- For Profit
- Employee range
- 1-10 employees
- Revenue range
- $0-$1M
- Founded
- 2012-06-12
Headquarters
- Headquarters
- Haverhill, England, United Kingdom
- Postal code
- CB9 8QP
- Country code
- GB
- Continent
- Europe